BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8741990)

  • 21. Synthesis of a carboxyl linker containing Pk trisaccharide.
    Hsieh SY; Jan MD; Patkar LN; Chen CT; Lin CC
    Carbohydr Res; 2005 Jan; 340(1):49-57. PubMed ID: 15620666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of enterohaemorrhagic Escherichia coli by the detection of vero toxin (or Shiga toxin)].
    Yamasaki S; Takeda Y
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 1999; 10(1):51-7. PubMed ID: 10651523
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and conformational analysis of an alpha-D-mannopyranosyl-(1-->2)-alpha-D-mannopyranosyl-(1-->6)-alpha-D-mannopyranose mimic.
    Mari S; Sánchez-Medina I; Mereghetti P; Belvisi L; Jiménez-Barbero J; Bernardi A
    Carbohydr Res; 2007 Sep; 342(12-13):1859-68. PubMed ID: 17420008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trisaccharide mimetics of the aminoglycoside antibiotic neomycin.
    Rao Y; Venot A; Swayze EE; Griffey RH; Boons GJ
    Org Biomol Chem; 2006 Apr; 4(7):1328-37. PubMed ID: 16557321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of the terminal trisaccharide unit of the lipo-oligosaccharide from Mycobacterium linda.
    Gurjar MK; Srinivas NR
    Carbohydr Res; 1993 Sep; 247():309-13. PubMed ID: 8221724
    [No Abstract]   [Full Text] [Related]  

  • 26. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes.
    Saleh MT; Ferguson J; Boggs JM; Gariépy J
    Biochemistry; 1996 Jul; 35(29):9325-34. PubMed ID: 8755710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic studies on the trisaccharide intermediate of resin glycoside merremoside H(2).
    Shen XQ; Xie L; Gao L; He LL; Yang Q; Yang JS
    Carbohydr Res; 2009 Oct; 344(15):2063-8. PubMed ID: 19709649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and hydration of the amylopectin trisaccharide building blocks--Synthesis, NMR, and molecular dynamics.
    Hansen PI; Larsen FH; Motawia SM; Blennow A; Spraul M; Dvortsak P; Engelsen SB
    Biopolymers; 2008 Dec; 89(12):1179-93. PubMed ID: 18712853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of tether length in nonglycosidically linked bivalent ligands that target sites 2 and 1 of a Shiga-like toxin.
    Kitov PI; Shimizu H; Homans SW; Bundle DR
    J Am Chem Soc; 2003 Mar; 125(11):3284-94. PubMed ID: 12630884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of propyl and 2-aminoethyl glycosides of alpha-D-galactosyl-(1-->3')-beta-lactoside.
    Yudina ON; Sherman AA; Nifantiev NE
    Carbohydr Res; 2001 Jun; 332(4):363-71. PubMed ID: 11438093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoselective synthesis of functionalized precursors of the CDEF and CDE 2,6-dideoxy-tetra- and trisaccharide units of durhamycins A and B.
    Durham TB; Roush WR
    Org Lett; 2003 May; 5(11):1875-8. PubMed ID: 12762675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a CHO cell-elongating factor produced by Vibrio cholerae O1.
    McCardell BA; Kothary MH; Hall RH; Sathyamoorthy V
    Microb Pathog; 2000 Jul; 29(1):1-8. PubMed ID: 10873485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A conformational dynamics study of alpha-l-Rhap-(1-->2)[alpha-l-Rhap-(1-->3)]-alpha-l-Rhap-OMe in solution by NMR experiments and molecular simulations.
    Eklund R; Lycknert K; Söderman P; Widmalm G
    J Phys Chem B; 2005 Oct; 109(42):19936-45. PubMed ID: 16853578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of specific inhibitors for heparin-binding proteins based on the cobra cardiotoxin structure: an effective synthetic strategy for rationally modified heparin-like disaccharides and a trisaccharide.
    Ke W; Whitfield DM; Brisson JR; Enright G; Jarrell HC; Wu WG
    Carbohydr Res; 2005 Feb; 340(3):355-72. PubMed ID: 15680590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An improvement in the bending ability of a hinged trisaccharide with the assistance of a sugar-sugar interaction.
    Yuasa H; Izumi T; Mitsuhashi N; Kajihara Y; Hashimoto H
    Chemistry; 2005 Nov; 11(22):6478-90. PubMed ID: 16094687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild one-pot preparation of glycosyl bromides.
    Hunsen M; Long DA; D'Ardenne CR; Smith AL
    Carbohydr Res; 2005 Dec; 340(17):2670-4. PubMed ID: 16216229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of recombinant shiga-like toxin type I B subunit.
    Austin PR; Hovde CJ
    Protein Expr Purif; 1995 Dec; 6(6):771-9. PubMed ID: 8746629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor.
    St Hilaire PM; Boyd MK; Toone EJ
    Biochemistry; 1994 Dec; 33(48):14452-63. PubMed ID: 7981205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-pot-synthesis of alpha-linked deoxy sugar trisaccharides.
    Köpper S; Thiem J
    Carbohydr Res; 1994 Jul; 260(2):219-32. PubMed ID: 8069874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.